Basel Medical Group (BMGL) Competitors $0.60 -0.02 (-2.78%) Closing price 05/22/2026 03:57 PM EasternExtended Trading$0.60 +0.01 (+1.34%) As of 05/22/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BMGL vs. EUDA, CCM, ACON, MGRX, and MRAIShould you buy Basel Medical Group stock or one of its competitors? MarketBeat compares Basel Medical Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Basel Medical Group include EUDA Health (EUDA), Concord Medical Services (CCM), Aclarion (ACON), Mangoceuticals (MGRX), and Marpai (MRAI). These companies are all part of the "healthcare" industry. BMGL vs. EUDABMGL vs. CCMBMGL vs. ACONBMGL vs. MGRXBMGL vs. MRAIHow does Basel Medical Group compare to EUDA Health?Basel Medical Group (NASDAQ:BMGL) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment. Which has preferable earnings and valuation, BMGL or EUDA? EUDA Health has lower revenue, but higher earnings than Basel Medical Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical Group$8.90M1.26-$9.50MN/AN/AEUDA Health$6.82M6.41-$2.77M-$2.40N/A Which has more volatility and risk, BMGL or EUDA? Basel Medical Group has a beta of 0.07, indicating that its share price is 93% less volatile than the broader market. Comparatively, EUDA Health has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market. Do analysts rate BMGL or EUDA? EUDA Health has a consensus target price of $55.00, indicating a potential upside of 216.82%. Given EUDA Health's stronger consensus rating and higher possible upside, analysts plainly believe EUDA Health is more favorable than Basel Medical Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00EUDA Health 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is BMGL or EUDA more profitable? Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A EUDA Health N/A N/A N/A Do institutionals and insiders believe in BMGL or EUDA? 4.4% of EUDA Health shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer BMGL or EUDA? In the previous week, Basel Medical Group had 1 more articles in the media than EUDA Health. MarketBeat recorded 1 mentions for Basel Medical Group and 0 mentions for EUDA Health. Basel Medical Group's average media sentiment score of 0.00 equaled EUDA Health'saverage media sentiment score. Company Overall Sentiment Basel Medical Group Neutral EUDA Health Neutral SummaryEUDA Health beats Basel Medical Group on 7 of the 9 factors compared between the two stocks.How does Basel Medical Group compare to Concord Medical Services?Basel Medical Group (NASDAQ:BMGL) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation. Does the media favor BMGL or CCM? In the previous week, Concord Medical Services had 1 more articles in the media than Basel Medical Group. MarketBeat recorded 2 mentions for Concord Medical Services and 1 mentions for Basel Medical Group. Concord Medical Services' average media sentiment score of 0.30 beat Basel Medical Group's score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Basel Medical Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Concord Medical Services 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger valuation & earnings, BMGL or CCM? Basel Medical Group has higher earnings, but lower revenue than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical Group$8.90M1.26-$9.50MN/AN/AConcord Medical Services$65.85M0.32-$13.27MN/AN/A Do analysts rate BMGL or CCM? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is BMGL or CCM more profitable? Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A Concord Medical Services N/A N/A N/A Which has more risk and volatility, BMGL or CCM? Basel Medical Group has a beta of 0.07, suggesting that its share price is 93% less volatile than the broader market. Comparatively, Concord Medical Services has a beta of -1.09, suggesting that its share price is 209% less volatile than the broader market. SummaryBasel Medical Group and Concord Medical Services tied by winning 3 of the 6 factors compared between the two stocks.How does Basel Medical Group compare to Aclarion?Aclarion (NASDAQ:ACON) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation. Is ACON or BMGL more profitable? Basel Medical Group has a net margin of 0.00% compared to Aclarion's net margin of -10,320.51%. Basel Medical Group's return on equity of 0.00% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets Aclarion-10,320.51% -54.41% -51.71% Basel Medical Group N/A N/A N/A Which has better earnings and valuation, ACON or BMGL? Aclarion has higher earnings, but lower revenue than Basel Medical Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$80K98.71-$7.23M-$9.03N/ABasel Medical Group$8.90M1.26-$9.50MN/AN/A Do institutionals and insiders believe in ACON or BMGL? 7.5% of Aclarion shares are held by institutional investors. 0.8% of Aclarion shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer ACON or BMGL? In the previous week, Basel Medical Group had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for Basel Medical Group and 0 mentions for Aclarion. Aclarion's average media sentiment score of 1.00 beat Basel Medical Group's score of 0.00 indicating that Aclarion is being referred to more favorably in the media. Company Overall Sentiment Aclarion Positive Basel Medical Group Neutral Which has more risk & volatility, ACON or BMGL? Aclarion has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Basel Medical Group has a beta of 0.07, suggesting that its share price is 93% less volatile than the broader market. Do analysts prefer ACON or BMGL? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryAclarion beats Basel Medical Group on 6 of the 11 factors compared between the two stocks.How does Basel Medical Group compare to Mangoceuticals?Mangoceuticals (NASDAQ:MGRX) and Basel Medical Group (NASDAQ:BMGL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation. Is MGRX or BMGL more profitable? Basel Medical Group has a net margin of 0.00% compared to Mangoceuticals' net margin of -4,639.13%. Basel Medical Group's return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mangoceuticals-4,639.13% -112.00% -104.96% Basel Medical Group N/A N/A N/A Which has better earnings and valuation, MGRX or BMGL? Basel Medical Group has higher revenue and earnings than Mangoceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMangoceuticals$460K16.83-$20.64M-$1.49N/ABasel Medical Group$8.90M1.26-$9.50MN/AN/A Do institutionals and insiders believe in MGRX or BMGL? 56.7% of Mangoceuticals shares are held by institutional investors. 16.0% of Mangoceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer MGRX or BMGL? In the previous week, Mangoceuticals had 2 more articles in the media than Basel Medical Group. MarketBeat recorded 3 mentions for Mangoceuticals and 1 mentions for Basel Medical Group. Basel Medical Group's average media sentiment score of 0.00 beat Mangoceuticals' score of -0.32 indicating that Basel Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mangoceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Basel Medical Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, MGRX or BMGL? Mangoceuticals has a beta of 2.12, suggesting that its share price is 112% more volatile than the broader market. Comparatively, Basel Medical Group has a beta of 0.07, suggesting that its share price is 93% less volatile than the broader market. Do analysts prefer MGRX or BMGL? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mangoceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryBasel Medical Group beats Mangoceuticals on 6 of the 11 factors compared between the two stocks.How does Basel Medical Group compare to Marpai?Marpai (NASDAQ:MRAI) and Basel Medical Group (NASDAQ:BMGL) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation. Does the media prefer MRAI or BMGL? In the previous week, Basel Medical Group had 1 more articles in the media than Marpai. MarketBeat recorded 1 mentions for Basel Medical Group and 0 mentions for Marpai. Marpai's average media sentiment score of 0.00 equaled Basel Medical Group'saverage media sentiment score. Company Overall Sentiment Marpai Neutral Basel Medical Group Neutral Do institutionals and insiders believe in MRAI or BMGL? 49.8% of Marpai shares are held by institutional investors. 46.1% of Marpai shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is MRAI or BMGL more profitable? Basel Medical Group has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% Basel Medical Group N/A N/A N/A Do analysts prefer MRAI or BMGL? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marpai 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has better earnings and valuation, MRAI or BMGL? Basel Medical Group has lower revenue, but higher earnings than Marpai. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.20-$28.75M-$0.87N/ABasel Medical Group$8.90M1.26-$9.50MN/AN/A Which has more risk & volatility, MRAI or BMGL? Marpai has a beta of 4.38, suggesting that its share price is 338% more volatile than the broader market. Comparatively, Basel Medical Group has a beta of 0.07, suggesting that its share price is 93% less volatile than the broader market. SummaryBasel Medical Group beats Marpai on 6 of the 10 factors compared between the two stocks. Get Basel Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BMGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BMGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BMGL vs. The Competition ExportMetricBasel Medical GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.22M$8.28B$6.44B$12.34BDividend YieldN/A2.98%2.76%5.28%P/E RatioN/A16.5017.9422.90Price / Sales1.2618.86552.9986.23Price / CashN/A84.4843.6856.73Price / Book2.995.7710.367.14Net Income-$9.50M$180.93M$3.56B$335.80M7 Day Performance-9.02%59.84%5.12%3.02%1 Month Performance-3.71%49.57%3.54%2.48%1 Year Performance-56.42%4.96%34.14%35.08% Basel Medical Group Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BMGLBasel Medical Group0.1393 of 5 stars$0.60-2.8%N/A-56.4%$11.22M$8.90MN/A36News CoveragePositive NewsEUDAEUDA Health1.9195 of 5 stars$14.60+1.0%$55.00+276.7%-76.9%$36.72M$6.82MN/A2Gap DownCCMConcord Medical Services0.6919 of 5 stars$5.26+4.0%N/A-31.7%$22.45M$460.51MN/A970ACONAclarion1.1704 of 5 stars$3.16-1.9%N/A-52.1%$7.78M$80KN/A7Analyst UpgradeMGRXMangoceuticals1.0084 of 5 stars$0.44+11.9%N/A-73.3%$7.47M$460KN/A3Positive NewsEarnings Report Related Companies and Tools Related Companies EUDA Alternatives CCM Alternatives ACON Alternatives MGRX Alternatives MRAI Alternatives ADVB Alternatives BRTX Alternatives BGLC Alternatives ATPC Alternatives DHAC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BMGL) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredSpaceX controls two-thirds of all satellites - and it is about to go publicSpaceX is targeting an IPO on June 11th, with trading set to begin June 12th and the roadshow kicking off June...NXT Wave Research | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredThe worst mistake you can make with the SpaceX IPOThe $1.75 trillion SpaceX IPO is generating massive hype - but history shows retail investors who pile in on d...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basel Medical Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Basel Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
